Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 3Thoracic 2Sarcoma 2Plasma cell 2Lymphoid 2Other hematologic neoplasm 1Classical hematology 1

Conditions

Sarcoma 54Dendritic Cell Sarcoma, Interdigitating 38Lymphoma 37Burkitt Lymphoma 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Large B-Cell, Diffuse 27Leukemia 27Lymphoma, Non-Hodgkin 25Recurrence 24Myelodysplastic Syndromes 24Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Follicular 23Lymphoma, Mantle-Cell 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, B-Cell, Marginal Zone 21Leukemia, Myeloid, Acute 21Neuroectodermal Tumors, Primitive, Peripheral 19Hodgkin Disease 19Osteosarcoma 18Multiple Myeloma 18Myeloproliferative Disorders 17Central Nervous System Neoplasms 17Astrocytoma 17Neoplasms, Plasma Cell 16Leukemia, Myeloid, Chronic-Phase 16Rhabdomyosarcoma 15Leukemia, Myeloid, Accelerated Phase 15Blast Crisis 15Ovarian Neoplasms 14Neuroblastoma 13

Interventions

apatinib 4Ifosfamide 2Filgrastim 2Etoposide 2selinexor 1glucarpidase 1camrelizumab 1Vincristine 1Radiotherapy 1Procarbazine 1Pharmaceutical Preparations 1Methotrexate 1Lomustine 1Imatinib Mesylate 1Genetic Therapy 1Fibroblast Growth Factor 7 1Drug Combinations 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Filgrastim × Sarcoma × Clear all
NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Indiana University

Phase 1 Completed
10 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT00004132 2013-06-26

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Radiation Injuries, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡